Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes

Result code in IS VaVaI
<a href="https://www.isvavai.cz/riv?ss=detail&h=RIV%2F00023736%3A_____%2F16%3A00011567" target="_blank" >RIV/00023736:_____/16:00011567 - isvavai.cz</a>
Result on the web
<a href="http://dx.doi.org/10.1182/blood-2016-07-728766" target="_blank" >http://dx.doi.org/10.1182/blood-2016-07-728766</a>
DOI - Digital Object Identifier
<a href="http://dx.doi.org/10.1182/blood-2016-07-728766" target="_blank" >10.1182/blood-2016-07-728766</a>

Result language
angličtina
Original language name
Cytopenia levels for aiding establishment of the diagnosis of myelodysplastic syndromes
Original language description
The recent article by Arber et al detailing the 2016 revision of the World Health Organization (WHO) classification of myeloid malignancies and AML was timely and germane. Regarding myelodysplastic syndromes (MDS), the authors indicate diagnostic criteria, which include levels of dysplasia and cytopenias. Being cognizant of these conditional blood count variations, we recommend that standard hematologic values be used to define cytopenias in MDS and believe a modification of the WHO definition of cytopenias as one of the criteria (in addition to definitive morphologic and/or cytogenetic findings) to diagnose MDS would be valuable and most accurate
Czech name
—
Czech description
—

Type
J<sub>x</sub> - Unclassified - Peer-reviewed scientific article (Jimp, Jsc and Jost)
CEP classification
FD - Oncology and haematology
OECD FORD branch
—

Publication year
2016
Confidentiality
S - Úplné a pravdivé údaje o projektu nepodléhají ochraně podle zvláštních právních předpisů

Similar results(10)